Skip to content Skip to footer
exclusiveslungcancer1015ap_853935.jpg

First-in-human trial for new lung cancer immunotherapy

Cancer Research UK and Vaccitech Oncology Limited (VOLT), announced Wednesday that a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer. The vaccine treatment developed by VOLT, a strategic collaboration between Vaccitech Ltd and the Ludwig Institute for Cancer Research, is…

Read More